Skip to content

HAART reduces liver damage in HIV / hepatitis C co-infected patients

Primary drug resistance has limited effect on disease progression and response to treatment

Premature to say atazanavir not linked to fat loss, says lipodystrophy expert

Clostridium difficile most common cause of bacterial diarrhoea in HIV-positive patients

Neurological side-effects of efavirenz mild and transient, study claims

HIV-positive injecting drug users who are infected with HTLV-II less are less likely to progress to AIDS

Less than half of deaths at London HIV clinic due to AIDS since 1998

Microbicide gel can prevent HIV and herpes infection of human cells

Higher doses of pegylated interferon or ribavirin improve hepatitis C treatment response rates